story of the week
Liraglutide for Obesity in Those With Severe Mental Illness
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Use of Liraglutide 3.0 mg Daily in the Management of Overweight and Obesity in People With Schizophrenia, Schizoaffective Disorder and First Episode Psychosis: Results of a Pilot Randomised Double-Blind Placebo-Controlled Trial
Diabetes Obes Metab 2021 Feb 02;[EPub Ahead of Print], CA Whicher, HC Price, P Phiri, S Rathod, K Barnard-Kelly, K Ngianga, K Thorne, C Asher, RC Peveler, J McCarthy, RI HoltFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.